Nippon Shikizai buys shares in Orleans Cosmetics

Japanese Nippon Shikizai, a make up and skin care contract manufacturer, reveals that its 100% subsidiary, Thepenier Pharma Industrie, has acquired shares of Orleans Cosmetics.

Nippon Shikizai obtained issued shares of the French original equipment manufacturer (OEM), making it a second-generation subsidiary.

Acquisition agreement

European Orléans Cosmetics belongs to the prestigious Cosmetic Valley — an established commercial collection of cosmetic manufacturers — that offer OEM services for cosmetics manufacturing to multiple nations.

The Cosmetic Valley area is home to a selection of research institutes including universities and national research institutes that together lead cosmetics developments around the world.

The agreement was made as the leading group, which has a significant presence in both Japan and France, intends to increase global production capacity in both countries and strengthen expansion efforts through further R&D activities and marketing drives.

As part of the agreement, Tsuyoshi Hasuo, the former Executive Officer and President of Thepenier Pharma Industrie, will now become the Executive Officer and President of Orléans Cosmetics.

Long-term strategy

This acquisition forms a solid decisive step towards realising the Japan cosmetics name’s global strategy. It aims to expand its product portfolio, up the production capacity of cosmetic products and increase existing R&D initiatives.

To support its management strategy, Nippon Shikizai Group aims to target both domestic and global consumers in its ongoing operations through continuing to develop a variety of make up and skin formulas.

“As part of its important group management strategy, Thépenier Pharma will extend its product portfolio and know-how in the makeup category, and will be able to offer a full range of made in France products and services, similar to those already proposed by Nippon Shikizai in Asia and in North America,” the company announced in a press release.

"Through this transaction, the Group will be able to increase its global production capacity and to accelerate globalisation of its research and development, and marketing activities.”